Effects of single or combined administration of salmon calcitonin and omega-3 fatty acids vs. diclofenac sodium in sodium monoiodoacetate-induced knee osteoarthritis in male Wistar rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 28, Issue 6, 2017, Pages 573-582

  Adeyemi, Wale J ^a   Olayaki, Luqman A ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

antioxidants; calcitonin; diclofenac sodium; omega 3 fatty acids; osteoarthritis

Indexed keywords

ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; CATALASE; COLLAGEN TYPE 2; COLLAGEN TYPE 2 ALPHA 1; DICLOFENAC; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; IODOACETIC ACID; MALONALDEHYDE; OMEGA 3 FATTY ACID; SALCATONIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; URIC ACID; CALCITONIN; COLLAGEN TYPE 1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; KNEE OSTEOARTHRITIS; LOW DRUG DOSE; MALE; MONOTHERAPY; NONHUMAN; RAT; TREATMENT OUTCOME; ANIMAL; BLOOD; CHEMICALLY INDUCED; DOSE RESPONSE; ENZYMOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; CALCITONIN; COLLAGEN TYPE I; COLLAGEN TYPE II; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; INTERLEUKIN-6; IODOACETIC ACID; MALE; MALONDIALDEHYDE; OSTEOARTHRITIS, KNEE; RATS; SUPEROXIDE DISMUTASE; URIC ACID;

EID: 85033804929     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2017-0032     Document Type: Article

References (44)

1. Sharma L, Kapoor D, Issa S. Epidemiology of osteoarthritis: an update. Curr Opin Rheumatol 2006;18:147-56.
2. Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities. PM R 2012;4:S10-9.
3. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006;20:3-25.
4. Symmons D, Mathers C, Pfleger B. Global burden of osteoarthritis in the year 2000. Available at: http://www.who.int/entity/ healthinfo/staisticsbod-osteoarthritis.pdf. Accessed on: 30th October 2016.
5. Bendele AM. Animal models of osteoarthritis. J Musculoskelet Neuronal Interact 2001;1:363-76.
6. Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC, et al. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Am J Physiol Endocrinol Metab 2007;293:E620-7.
7. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Monoiodoacetate- induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003;31:619-24.
8. Sidhaye A, Cheskin LJ. Pharmacological treatment of obesity. Adv Psychosom Med 2006;27:42-52.
9. Plaa GL, Witschi H. Chemicals, drugs, & lipid peroxidation. Ann Rev Pharmacol Toxicol 1976;16:125-41.
10. Dequeker J, Mokassa L, Aerssens J, Boonen S. Bone density and local growth factors in generalized osteoarthritis. Microsc Res Tech 1997;37:358-71.
11. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011;377:2115-26.
12. Bettica P, Cline G, Hart DJ, Meyer J, Spector TD. Evidence for increased bone resorption in patients with progressive knee osteoarthritis longitudinal results from the Chingford study. Arthritis Rheumat 2002;46:3178-84.
13. Sukhorebska MY, Yatsyshyn RI, Delva YV, Sandurska YV, Oliynyk OI. Osteoarthritis and metabolic syndrome: a current view of the problem. Ukr J Rheumatol 2013;1:51.
14. National Academy of Sciences. Guide for the care and use of laboratory animals. Washington, DC: The National Academies Press, 2011:1-246.
15. Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue1 G, Eguchi Y, et al. Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Dis 2011;12:134.
16. Berkoz M, Yalin S, Comelekoglu U, Bagis S. Effect of calcitonin on lipid peroxidation in ovariectomized rats. Eur J Chem 2010;1:4446.
17. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001;60:91-7.
18. Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 2007;6:2.
19. Knotty L, Averyy NC, Hollanderz AP, Tarltony JF. Regulation of osteoarthritis by omega-3 (n-3) polyunsaturated fatty acids in a naturally occurring model of disease. Osteoarthritis Cartilage 2011;19:1150-7.
20. Hogstrom M, Nordstrom P, Nordstrom A. N-3 fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 study. Am J Clin Nutr 2007;85:803-7.
21. Watkins BA, Li Y, Seifert MF. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 2006;17:282-9.
22. Hamdy RC, Daley DN. Oral calcitonin. Int J Womens Health 2012;4:471-9.
23. Furuichi H, Fukuyama R, Izumo N, Fujita T, Kohno T, Nakamuta H, et al. Bone-anabolic effect of salmon calcitonin on glucocorticoid- induced osteopenia in rats. Biol PharmBull 2000;23:946-51.
24. Dedrick DK, Goulet R, Huston L, Goldstein SA, Bole GG. Early bone changes in experimental osteoarthritis using microscopic computed tomography. J Rheumatol 1991;27:44-5.
25. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003;18:1206-16.
26. Kwan TS, Lajeunesse D, Pelletier JP, Martel-Pelletier J. Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol 2010;24:51-70.
27. Baca S, Altman RD, Dean DD. Calcitonin effects on rabbit articular cartilage explants. J Bone Miner Res 1992;7:S254.
28. Badurski J, Popko J, Zimnoch L, Nariszewicz K. Anabolic effects of salmon calcitonin on rat and mice joint cartilage. Bone 1995;18:S174.
29. Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, Qvist P, et al. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthritis Cartilage 2006;14:759-68.
30. Siamopoulos A, Challa A, Kapoglou V, Cholevas V, Mavridis AK, Lapatsanis PD. Effects of intranasal salmon calcitonin in juvenile idiopathic arthritis: an observational study. Calcif Tissue Int 2001;69:25-30.
31. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PK-Cepsilon inhibition. Proc Natl Acad Sci 2001;103:15184-9.
32. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004;350:29-37.
33. Todd PA, Sorkin EM. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988;35:244-85.
34. McAlindon TE, Jacques P, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648-56.
35. Surapaneni KM, Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J Med Sci 2007; 61:9-14.
36. Bhattacharya I, Saxena R, Gupta V. Efficacy of vitamin E in knee osteoarthritis management of North Indian geriatric population. Ther Adv Musculoskelet Dis 2012;4:11-9.
37. Manov I, Motarris H, Frumin I, Iancu TC. Hepatotoxicity of antinflammatory and analgesic drugs: ultrasructural aspects. Acta Pharmacol Sin 2006;27:259-72.
38. Ozgocmen S, Kaya H, Fadillioglu E. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res 2007;38:196-205.
39. Hatanaka E, Levada-Pires AC, Pithon-Curi TC, Curi R. Systematic study on ROS production induced by oleic, linoleic, and gammalinolenic acids in human and rat neutrophils. Free Radic Biol Med 2006;41:1124-32.
40. Obajimi O, Black KD, Glen I, Ross BM. Antioxidant modulation of oxidant-stimulated uptake and release of arachidonic acid in eicosapentaenoic acid-supplemented human lymphoma U937 cells. Prostaglandins Leukot Essent Fatty Acids 2007;76:65-71.
41. Sarkadi-Nagy E, Huang MC, Diau GY, Kirwan R, Chueh CA, Tschanz C, et al. Long chain polyunsaturate supplementation does not induce excess lipid peroxidation of piglet tissues. Eur J Nutr 2003;42:293-6.
42. Kesavulu MM, Kameswararao B, Apparao C, Kumar EG, Harinarayan CV. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab 2002;28:20-6.
43. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013;21:16-21.
44. Mancini L, Paul-Clark MJ, Rosignoli G, Hannon R, Martin JE, Macintyre I, et al. Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis. Am J Pathol 2007;170:1018-27.